ISRCTN ISRCTN84743489
DOI https://doi.org/10.1186/ISRCTN84743489
Protocol serial number 6258
Sponsor Derby Hospital NHS Foundation Trust (UK)
Funder British Renal Society (UK)
Submission date
19/05/2010
Registration date
19/05/2010
Last edited
13/12/2019
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Urological and Genital Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Stephen John
Scientific

Royal Derby Hospital
Uttoxeter Road
Derby
DE22 3NE
United Kingdom

Study information

Primary study designInterventional
Study designSingle centre non-randomised interventional treatment trial
Secondary study designNon randomised controlled trial
Study type Participant information sheet
Scientific titleCardiovascular and functional consequences of chronic kidney disease in older people: a single centre non-randomised interventional treatment trial
Study objectivesThe aim of this study is to investigate this area with an integrated range of non-invasive assessments, both without antihypertensive medication, and with BP control to published best-practice guidelines.
Ethics approval(s)Trent MREC, 15/03/2007, ref: 06/MRE04/73
Health condition(s) or problem(s) studiedTopic: Renal and Urogenital; Subtopic: Renal and Urogenital (all Subtopics); Disease: Renal
InterventionAntihypertensive therapy using standard agents to target BP 130/80 mmHg. Assessments are performed after antihypertensive washout, reintroduction and 12 months follow up.
Intervention typeOther
Primary outcome measure(s)

Changes in Baroreflex sensitivity (a composite marker of autonomic function) in response to antihypertensive therapy, assessed at each assessment

Key secondary outcome measure(s)

Assessed at each assessment:
1. Cardiovascular predictors of Falls propensity
2. Cardiovascular consequences of antihypertensive therapy

Completion date08/02/2010

Eligibility

Participant type(s)Patient
Age groupAdult
SexAll
Target sample size at registration80
Key inclusion criteria1. Aged greater than 70 years
2. CKD 3, 4 or hypertensive (greater than 130/80) with no renal disease
Key exclusion criteria1. Use of more than 3 drugs for blood pressure control
2. Likely to develop CKD 5 within one year
3. Poor mobility precluding completion of assessment
4. Diabetes
5. Abbreviated mental test (AMT) score < 8
6. Recent acute illness (within 3 months)
7. Ischaemic heart disease requiring beta-blockade (nitrates/nicorandil are permitted)
8. Involvement in another clinical trial within 3 months
9. Attending day hospital or attending falls reduction services
10. Residents in nursing or residential homes
11. Renovascular disease precluding ACE-inhibitor (ACEi) or Angiotensin Receptor Blocker (ARB) usage
12. BP prior to antihypertensive withdrawal > 160/90mmHg
13. Malignant hypertension
14. Severe peripheral vascular disease or significant valvular heart disease
15. Heart failure (NYHA III/IV) or other cause to prevent diuretic withdrawal
16. Atrial fibrillation or other significant arrhythmia (precludes pulse wave velocity (PWV) measurement)
17. Currently taking antihypertensive medication for which MRHA approval (CTA) has not been granted
18. Active Obstructive uropathy
Date of first enrolment01/08/2007
Date of final enrolment08/02/2010

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

Royal Derby Hospital
Derby
DE22 3NE
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes

Editorial Notes

13/12/2019: No publications found, verifying study status with principal investigator.
08/08/2016: No publications found in PubMed, verifying study status with principal investigator.